Axonics (AXNX) Stock Forecast, Price & News

Axonics (NASDAQ:AXNX) Frequently Asked Questions

Is Axonics a buy right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Axonics in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Axonics stock.
View analyst ratings for Axonics or view top-rated stocks.

When is Axonics' next earnings date?

Axonics is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Axonics.

How were Axonics' earnings last quarter?

Axonics, Inc. (NASDAQ:AXNX) announced its quarterly earnings results on Thursday, May, 5th. The company reported ($0.50) earnings per share for the quarter, topping analysts' consensus estimates of ($0.63) by $0.13. The company had revenue of $48.42 million for the quarter, compared to the consensus estimate of $45.37 million. Axonics had a negative net margin of 41.28% and a negative trailing twelve-month return on equity of 16.54%. The company's quarterly revenue was up 40.9% compared to the same quarter last year. During the same period last year, the business earned ($0.46) earnings per share.
View Axonics' earnings history.

What guidance has Axonics issued on next quarter's earnings?

Axonics updated its FY 2022 earnings guidance on Monday, May, 23rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $238.00 million-$238.00 million, compared to the consensus revenue estimate of $234.08 million.

What price target have analysts set for AXNX?

7 brokers have issued 1-year price objectives for Axonics' shares. Their forecasts range from $62.00 to $79.00. On average, they anticipate Axonics' share price to reach $70.17 in the next year. This suggests a possible upside of 34.1% from the stock's current price.
View analysts' price targets for Axonics or view top-rated stocks among Wall Street analysts.

Who are Axonics' key executives?

Axonics' management team includes the following people:

• Mr. Raymond W. Cohen, CEO & Director (Age 63, Pay $1.34M) (LinkedIn Profile)
• Mr. Danny L. Dearen, Pres & CFO (Age 59, Pay $790.2k) (LinkedIn Profile)
• Mr. Rinda K. Sama, Chief Operating Officer (Age 42, Pay $758.6k) (LinkedIn Profile)
• Dr. John Woock Ph.D., Exec. VP, Chief Marketing & Strategy Officer (Age 38, Pay $586.35k)
• Mr. Alfred J. Ford Jr., Chief Commercial Officer (Age 51, Pay $585.99k) (LinkedIn Profile)
• Mr. Guangqiang Jiang Ph.D., Chief Technology Officer (Age 48)
• Mr. Neil Bhalodkar, VP of Investor Relations
• Mr. Aaron Pettit, Gen. Counsel & Chief Compliance Officer
• Mr. Michael V. Williamson Esq., J.D., Sr. VP, Gen. & IP Counsel (Age 50)
• Dr. Karen L. Noblett M.A.S., M.D., Chief Medical Officer (Age 58)

What is Raymond W. Cohen's approval rating as Axonics' CEO?

12 employees have rated Axonics CEO Raymond W. Cohen on Glassdoor.com. Raymond W. Cohen has an approval rating of 89% among Axonics' employees.

Who are some of Axonics' key competitors?

Some companies that are related to Axonics include NovoCure (NVCR), Globus Medical (GMED), ShockWave Medical (SWAV), Penumbra (PEN), Integra LifeSciences (IART), Inspire Medical Systems (INSP), Tandem Diabetes Care (TNDM), ICU Medical (ICUI), iRhythm Technologies (IRTC), Inari Medical (NARI), Merit Medical Systems (MMSI), Haemonetics (HAE), NuVasive (NUVA), Beauty Health (SKIN) and Glaukos (GKOS).
View all of AXNX's competitors.

What other stocks do shareholders of Axonics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axonics investors own include Raytheon Technologies (RTX), (HON), Oasis Petroleum (OAS), Pfizer (PFE), Procter & Gamble (PG), Thermo Fisher Scientific (TMO), Cisco Systems (CSCO), CVS Health (CVS), AT&T (T) and Abbott Laboratories (ABT).

When did Axonics IPO?

(AXNX) raised $100 million in an initial public offering (IPO) on Wednesday, October 31st 2018. The company issued 6,700,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Morgan Stanley acted as the underwriters for the IPO and Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Axonics' stock symbol?

Axonics trades on the NASDAQ under the ticker symbol "AXNX."

Who are Axonics' major shareholders?

Axonics' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (7.37%), Vanguard Group Inc. (5.98%), Bellevue Group AG (4.35%), RTW Investments LP (3.70%), Loomis Sayles & Co. L P (3.27%) and Lord Abbett & CO. LLC (2.64%). Company insiders that own Axonics stock include Alfred J Ford Jr, Alfred J Ford, Jr, Bakker Juliet Tammenoms, Danny L Dearen, Jane E Kiernan, John Woock, Karen Noblett, Raymond W Cohen, Raymond W Cohen, Rinda Sama and Robert E Mcnamara.
View institutional ownership trends for Axonics.

Which major investors are selling Axonics stock?

AXNX stock was sold by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, RTW Investments LP, Goldman Sachs Group Inc., Vanguard Group Inc., Peregrine Capital Management LLC, Rhenman & Partners Asset Management AB, SG Americas Securities LLC, and BlackRock Inc.. Company insiders that have sold Axonics company stock in the last year include Danny L Dearen, Jane E Kiernan, John Woock, Karen Noblett, Raymond W Cohen, and Rinda Sama.
View insider buying and selling activity for Axonics or view top insider-selling stocks.

Which major investors are buying Axonics stock?

AXNX stock was purchased by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Next Century Growth Investors LLC, Champlain Investment Partners LLC, Bellevue Group AG, Loomis Sayles & Co. L P, Granite Investment Partners LLC, First Light Asset Management LLC, and Lisanti Capital Growth LLC.
View insider buying and selling activity for Axonics or or view top insider-buying stocks.

How do I buy shares of Axonics?

Shares of AXNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axonics' stock price today?

One share of AXNX stock can currently be purchased for approximately $52.33.

How much money does Axonics make?

Axonics has a market capitalization of $2.46 billion and generates $180.29 million in revenue each year. The company earns $-80.07 million in net income (profit) each year or ($1.81) on an earnings per share basis.

How many employees does Axonics have?

Axonics employs 517 workers across the globe.

What is Axonics' official website?

The official website for Axonics is www.axonics.com.

How can I contact Axonics?

Axonics' mailing address is 26 TECHNOLOGY DRIVE, IRVINE CA, 92618. The company can be reached via phone at (866) 722-5738, via email at [email protected], or via fax at 949-396-6321.